INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 428m ago
HOUSE PTR28m ago
SEC 13F27m ago
ROBINHOOD CHAIN27m ago
Public company

Altimmune, Inc.

ALTCIK 0001326190

EDGAR filingsOpen in network
Price$2.08
1 year-44.5%
Disclosed transactions21
Buys / sells3 / 0
Max Insider Score44
Connections with evidence9

ALT · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
HG
Howarth Alex G.Director
ALTAltimmune, Inc.
Grant or award
A—
160.0K sh
Nov 2, 2026Nov 4, 2026

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 2834 · Pharmaceutical Preparations · Nov 4, 2026
  • ← Insider ofevidence
    Greenleaf PeterDirector · Nov 4, 2026
  • ← Insider ofevidence
    Howarth Alex G.Director · Nov 4, 2026
  • ← Insider ofevidence
    Menziuso Richard ThomasPrincipal Accounting Officer · Oct 2, 2026
  • ← Insider ofevidence
traded Nov 2, 2026
+2d
SEC FORM 4

Evidence

9
GP
Greenleaf PeterDirector
ALTAltimmune, Inc.
Grant or award
A—
160.0K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence

9
MT
Menziuso Richard ThomasPrincipal Accounting Officer
ALTAltimmune, Inc.
Grant or award
A—
84.5K sh
Oct 1, 2026Oct 2, 2026
traded Oct 1, 2026
+1dSEC FORM 4

Evidence

9
MT
Menziuso Richard ThomasPrincipal Accounting Officer
ALTAltimmune, Inc.
Grant or award
A—
36.2K sh
Oct 1, 2026Oct 2, 2026
traded Oct 1, 2026
+1dSEC FORM 4

Evidence

33
DB
Durso Jerome BenedictDirector, President and CEO
ALTAltimmune, Inc.
Open-market purchase
BUY$44K
15.0K sh
Aug 13, 2026Aug 13, 2026
traded Aug 13, 2026
+0dSEC FORM 4

Evidence

9
LL
Lawver Teri LDirector
ALTAltimmune, Inc.
Grant or award
A—
48.8K sh
May 1, 2026May 1, 2026
traded May 1, 2026
+0dSEC FORM 4

Evidence

13
JM
Jordt Raymond MChief Business Officer
ALTAltimmune, Inc.
Grant or award
A$14K
4,571 sh
Jan 31, 2026Feb 2, 2026
traded Jan 31, 2026
+2dSEC FORM 4

Evidence

13
RS
Roberts M ScotChief Scientific Officer
ALTAltimmune, Inc.
Option exercise
M—
15.8K sh
Jan 27, 2026Jan 29, 2026
traded Jan 27, 2026
+2dSEC FORM 4

Evidence

13
JM
Jordt Raymond MChief Business Officer
ALTAltimmune, Inc.
Tax withholding
F$26K
4,229 sh
Jan 27, 2026Jan 29, 2026
traded Jan 27, 2026
+2dSEC FORM 4

Evidence

21
JM
Jordt Raymond MChief Business Officer
ALTAltimmune, Inc.
Option exercise
M—
15.8K sh
Jan 27, 2026Jan 29, 2026
traded Jan 27, 2026
+2dSEC FORM 4

Evidence

13
RS
Roberts M ScotChief Scientific Officer
ALTAltimmune, Inc.
Tax withholding
F$29K
4,748 sh
Jan 27, 2026Jan 29, 2026
traded Jan 27, 2026
+2dSEC FORM 4

Evidence

21
RS
Roberts M ScotChief Scientific Officer
ALTAltimmune, Inc.
Option exercise
M—
15.8K sh
Jan 27, 2026Jan 29, 2026
traded Jan 27, 2026
+2dSEC FORM 4

Evidence

17
JM
Jordt Raymond MChief Business Officer
ALTAltimmune, Inc.
Option exercise
M—
15.8K sh
Jan 27, 2026Jan 29, 2026
traded Jan 27, 2026
+2dSEC FORM 4

Evidence

21
RS
Roberts M ScotChief Scientific Officer
ALTAltimmune, Inc.
Option exercise
M—
14.6K sh
Jan 25, 2026Jan 27, 2026
traded Jan 25, 2026
+2dSEC FORM 4

Evidence

21
JM
Jordt Raymond MChief Business Officer
ALTAltimmune, Inc.
Option exercise
M—
14.6K sh
Jan 25, 2026Jan 27, 2026
traded Jan 25, 2026
+2dSEC FORM 4

Evidence

13
RS
Roberts M ScotChief Scientific Officer
ALTAltimmune, Inc.
Option exercise
M—
14.6K sh
Jan 25, 2026Jan 27, 2026
traded Jan 25, 2026
+2dSEC FORM 4

Evidence

13
RS
Roberts M ScotChief Scientific Officer
ALTAltimmune, Inc.
Tax withholding
F$24K
4,373 sh
Jan 25, 2026Jan 27, 2026
traded Jan 25, 2026
+2dSEC FORM 4

Evidence

17
JM
Jordt Raymond MChief Business Officer
ALTAltimmune, Inc.
Option exercise
M—
14.6K sh
Jan 25, 2026Jan 27, 2026
traded Jan 25, 2026
+2dSEC FORM 4

Evidence

13
JM
Jordt Raymond MChief Business Officer
ALTAltimmune, Inc.
Tax withholding
F$21K
3,855 sh
Jan 25, 2026Jan 27, 2026
traded Jan 25, 2026
+2dSEC FORM 4

Evidence

41
PW
Pisano WayneDirector
ALTAltimmune, Inc.
Open-market purchase
BUY$20K
5,000 sh
Jan 8, 2026Jan 9, 2026
traded Jan 8, 2026
+1dSEC FORM 4

Evidence

44
DB
Durso Jerome BenedictDirector
ALTAltimmune, Inc.
Open-market purchase
BUY$52K
12.5K sh
Dec 22, 2025Dec 22, 2025
traded Dec 22, 2025
+0dSEC FORM 4

Evidence

Lawver Teri L
Director · May 1, 2026
  • ← Insider ofevidence
    Jordt Raymond MChief Business Officer · Jan 27, 2026
  • ← Insider ofevidence
    Roberts M ScotChief Scientific Officer · Jan 27, 2026
  • ← Insider ofevidence
    Pisano WayneDirector · Jan 9, 2026
  • ← Insider ofevidence
    Durso Jerome BenedictDirector · Dec 22, 2025